{"id":1855,"date":"2013-08-19T16:25:41","date_gmt":"2013-08-19T16:25:41","guid":{"rendered":"http:\/\/test-medrazgl.aed-baza.si\/?p=1855"},"modified":"2013-08-19T16:25:41","modified_gmt":"2013-08-19T16:25:41","slug":"evaluation-of-efficacy-safety-and-acceptability-of-orodispersible-risperidone-in-patients-with-schizophrenia-bipolar-mania-and-behavioural-disturbances-in-dementia-patients","status":"publish","type":"post","link":"https:\/\/medrazgl.si\/en\/evaluation-of-efficacy-safety-and-acceptability-of-orodispersible-risperidone-in-patients-with-schizophrenia-bipolar-mania-and-behavioural-disturbances-in-dementia-patients\/","title":{"rendered":"Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients"},"content":{"rendered":"<div>\n<p>Second generation antipsychotics are currently the drugs of choice for the treatment of schiz\u00adophrenia and bipolar mania, as well as for behavioural symptoms in patients with dementia. All these diseases represent an important healthcare problem in Europe, so that early treat\u00adment is recommended. Due to improved patient compliance, new pharmaceutical forms of already proven therapy are developed. Orally disintegrated tablets disintegrate rapidly in the mouth without water. Therefore, a study was conducted with risperidone (Torendo\u00ae Q-Tab\u00ae, Krka, d. d., Novo Mesto) in 487 patients with schizophrenia, bipolar mania and behavioural disturbances in dementia patients. Risperidone in recommended doses significantly improved symptoms in 77% of patients. Its tolerability was very good, as adverse reactions related to\u00a0the medicine occurred in 11.9% of the patients. 90% of the patients were satisfied with treat\u00adment with Torendo\u00ae Q-Tab\u00ae, and this proved very good acceptability of our risperidone in the orodispersible formulation. The most frequent reason why patients choose Torendo Q-Tab were: easy swallowing of the medicine, easy administration\/intake of the medicine, ability to take it at anyplace and anytime, greater comfort that taking the medicine is less conspic\u00aduous, improved ability to perform everyday activities.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Second generation antipsychotics are currently the drugs of choice for the treatment of schiz\u00adophrenia and bipolar mania, as well as for behavioural symptoms in patients with dementia. All these diseases represent an important healthcare problem in Europe, so that early treat\u00adment is recommended. Due to improved patient compliance, new pharmaceutical forms of already proven therapy [&hellip;]<\/p>\n","protected":false},"author":30,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[381,406],"tags":[],"class_list":["post-1855","post","type-post","status-publish","format-standard","hentry","category-3-2008-archive","category-sponsored-articles"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients - Dru\u0161tvo Medicinski razgledi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients - Dru\u0161tvo Medicinski razgledi\" \/>\n<meta property=\"og:description\" content=\"Second generation antipsychotics are currently the drugs of choice for the treatment of schiz\u00adophrenia and bipolar mania, as well as for behavioural symptoms in patients with dementia. All these diseases represent an important healthcare problem in Europe, so that early treat\u00adment is recommended. Due to improved patient compliance, new pharmaceutical forms of already proven therapy [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/\" \/>\n<meta property=\"og:site_name\" content=\"Dru\u0161tvo Medicinski razgledi\" \/>\n<meta property=\"article:published_time\" content=\"2013-08-19T16:25:41+00:00\" \/>\n<meta name=\"author\" content=\"\u010crt Zavrnik\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u010crt Zavrnik\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\\\/\"},\"author\":{\"name\":\"\u010crt Zavrnik\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/80418a5a6b59976483b5d19fc87a9092\"},\"headline\":\"Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients\",\"datePublished\":\"2013-08-19T16:25:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\\\/\"},\"wordCount\":212,\"commentCount\":0,\"articleSection\":[\"3\",\"Sponsored articles\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/medrazgl.si\\\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\\\/\",\"url\":\"https:\\\/\\\/medrazgl.si\\\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\\\/\",\"name\":\"Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients - Dru\u0161tvo Medicinski razgledi\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#website\"},\"datePublished\":\"2013-08-19T16:25:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/80418a5a6b59976483b5d19fc87a9092\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medrazgl.si\\\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medrazgl.si\\\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/medrazgl.si\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#website\",\"url\":\"https:\\\/\\\/medrazgl.si\\\/\",\"name\":\"Dru\u0161tvo Medicinski razgledi\",\"description\":\"Dru\u0161tvo Medicinski razgledi\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medrazgl.si\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medrazgl.si\\\/#\\\/schema\\\/person\\\/80418a5a6b59976483b5d19fc87a9092\",\"name\":\"\u010crt Zavrnik\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b98a6d0f77e61d69dd0d0d8b50dae2e33c8a851e0d1bd0dd468c8998ea95fcc8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b98a6d0f77e61d69dd0d0d8b50dae2e33c8a851e0d1bd0dd468c8998ea95fcc8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b98a6d0f77e61d69dd0d0d8b50dae2e33c8a851e0d1bd0dd468c8998ea95fcc8?s=96&d=mm&r=g\",\"caption\":\"\u010crt Zavrnik\"},\"url\":\"https:\\\/\\\/medrazgl.si\\\/en\\\/author\\\/crt-zavrnik\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients - Dru\u0161tvo Medicinski razgledi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/","og_locale":"en_US","og_type":"article","og_title":"Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients - Dru\u0161tvo Medicinski razgledi","og_description":"Second generation antipsychotics are currently the drugs of choice for the treatment of schiz\u00adophrenia and bipolar mania, as well as for behavioural symptoms in patients with dementia. All these diseases represent an important healthcare problem in Europe, so that early treat\u00adment is recommended. Due to improved patient compliance, new pharmaceutical forms of already proven therapy [&hellip;]","og_url":"https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/","og_site_name":"Dru\u0161tvo Medicinski razgledi","article_published_time":"2013-08-19T16:25:41+00:00","author":"\u010crt Zavrnik","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u010crt Zavrnik","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/#article","isPartOf":{"@id":"https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/"},"author":{"name":"\u010crt Zavrnik","@id":"https:\/\/medrazgl.si\/#\/schema\/person\/80418a5a6b59976483b5d19fc87a9092"},"headline":"Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients","datePublished":"2013-08-19T16:25:41+00:00","mainEntityOfPage":{"@id":"https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/"},"wordCount":212,"commentCount":0,"articleSection":["3","Sponsored articles"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/","url":"https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/","name":"Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients - Dru\u0161tvo Medicinski razgledi","isPartOf":{"@id":"https:\/\/medrazgl.si\/#website"},"datePublished":"2013-08-19T16:25:41+00:00","author":{"@id":"https:\/\/medrazgl.si\/#\/schema\/person\/80418a5a6b59976483b5d19fc87a9092"},"breadcrumb":{"@id":"https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medrazgl.si\/ocena-ucinkovitosti-varnosti-in-sprejemljivosti-orodisperzibilnega-risperidona-pri-bolnikih-s-shizofrenijo-ali-bipolarno-manijo-in-pri-vedenjskih-motnjah-dementnih-bolnikov\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medrazgl.si\/en\/"},{"@type":"ListItem","position":2,"name":"Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients"}]},{"@type":"WebSite","@id":"https:\/\/medrazgl.si\/#website","url":"https:\/\/medrazgl.si\/","name":"Dru\u0161tvo Medicinski razgledi","description":"Dru\u0161tvo Medicinski razgledi","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medrazgl.si\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/medrazgl.si\/#\/schema\/person\/80418a5a6b59976483b5d19fc87a9092","name":"\u010crt Zavrnik","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b98a6d0f77e61d69dd0d0d8b50dae2e33c8a851e0d1bd0dd468c8998ea95fcc8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b98a6d0f77e61d69dd0d0d8b50dae2e33c8a851e0d1bd0dd468c8998ea95fcc8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b98a6d0f77e61d69dd0d0d8b50dae2e33c8a851e0d1bd0dd468c8998ea95fcc8?s=96&d=mm&r=g","caption":"\u010crt Zavrnik"},"url":"https:\/\/medrazgl.si\/en\/author\/crt-zavrnik\/"}]}},"_links":{"self":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts\/1855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/users\/30"}],"replies":[{"embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/comments?post=1855"}],"version-history":[{"count":0,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/posts\/1855\/revisions"}],"wp:attachment":[{"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/media?parent=1855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/categories?post=1855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medrazgl.si\/en\/wp-json\/wp\/v2\/tags?post=1855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}